Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,152.04
(
0.23%
)
US TECH 100
26,424.40
(
-0.15%
)
Dow Jones
49,430.40
(
1.16%
)
Brent Oil
110.45
(
-1.72%
)
Bitcoin
76,329.98
(
0.73%
)
News Focus
News Focus
Post# of 257471
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122911
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: 10bags post# 235996

Friday, 08/13/2021 2:45:05 PM

Friday, August 13, 2021 2:45:05 PM

Post# of 257471
SESN receives CRL for Vicineum in NMIBC:

https://finance.yahoo.com/news/sesen-bio-receives-complete-response-184000117.html

The FDA has determined that it cannot approve the BLA for Vicineum in its present form and has provided recommendations specific to additional clinical/statistical data and analyses in addition to Chemistry, Manufacturing and Controls (CMC) issues pertaining to a recent pre-approval inspection and product quality.

Other than those things, the BLA is in pretty good shape, LOL.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today